Loading clinical trials...
Loading clinical trials...
Effectiveness and Safety of Venetoclax in Combination With Azacitidine in Patients With Acute Myeloid Leukemia in Real Life Clinical Practice
Conditions
Locations
7
Colombia
Hospital Pablo Tobón Uribe /ID# 248569
Medellín, Antioquia, Colombia
Hospital Alma Mater de Antioquia /ID# 248562
Medellin, Bogota D.C., Colombia
Sociedad de Oncologia y Hematologia del Cesar /ID# 248615
Valledupar, Cesar Department, Colombia
Coorp Hosp Juan Ciudad Sede Hospital Universitario Mayor Mederi /ID# 248570
Bogota DC, Cundinamarca, Colombia
Clinica del Country /ID# 248430
Bogota, Cundinamarca, Colombia
Fundación Santa Fé De Bogotá /ID# 248563
Bogotá, Cundinamarca, Colombia
Start Date
November 30, 2023
Primary Completion Date
November 1, 2026
Completion Date
November 1, 2026
Last Updated
August 8, 2025
NCT06285890
NCT06220162
NCT04065399
NCT06484062
NCT04628026
NCT06994676
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions